JAK2 and breast carcinoma: Previous research has indicated that ZSWIM4 reduces the sensitivity of breast cancer cells to JAK2 inhibitor [34], and ZSWIM4 might play a role in the response to vitamin D treatment in colon tissues [35], although the underlying mechanism is not elucidated yet.